Is HRT Safe? What to Tell Patients About Cancer and Clots

Your patient is ready to start hormone therapy. Then she asks one question. My grandmother had breast cancer, so I can never take this, right? If the answer is not clear, she leaves. And she tells her family what she heard. In this episode, Nico Misleh, MSN, FNP-C makes a case. Most of the safety questions patients bring to an HRT or TRT consult come from old data. He also argues that providers who can answer them calmly keep patients who would otherwise walk out. He works through the questions that stumped him early in practice and still catch providers today. On the female side: why a family history of breast cancer is a risk factor to weigh. It is not a contraindication. Personal history and BRCA status matter more. Why the blood clot fear traces back to synthetic hormones, birth control pills and conjugated equine estrogen with progestins. Why a patient at 38 or 40 is not too young when symptoms and labs line up. Why waiting for 12 months without a period is a legacy rule. On the male side: why lifestyle optimization and testosterone replacement are different projects. What TRT does to LH, FSH and spermatogenesis, and how hCG or enclomiphene keep fertility on the table. What the 2023 traverse trial found for major adverse cardiovascular events. How the saturation model replaced the 1941 Huggins hypothesis on prostate cancer. Why you should expect a small, stable PSA rise in the first 3 to 6 months of TRT. Then the practical side. Nico reframes the question patients ask most: will I have to take this forever. His answer is replacement. It is not dependency. It sits in the same category as insulin or thyroid hormone. Stopping does not cause a rebound. Physiology returns to where it would have been without treatment. And he makes the case for answering these questions before the patient asks. Tell a man his PSA will rise before it does. Share the traverse data before his cardiologist raises it. Some of your patients stall at the consult. Others start therapy and then hear doubt from family, friends or another provider. This episode is for you. It gives you the framework and the words to answer. Nico teaches the physiology behind each of these answers inside the HRT University Master Course. The course is jointly accredited by ACCME, ACPE, and ANCC. Pinnacle Conference, LLC is the accredited provider, and HRT University plans and implements the course, so providers earn 30 CE hours, including 12 hours of pharmacology. Learn more about the Master Course at https://hrtuniversity.com/hrtcourse/ Hear more episodes at https://hrtuniversity.com/hrtu-podcast/ Read the Second Opinion newsletter at https://nicomislehnp.kit.com/8050eeea5f Join the provider community at https://www.facebook.com/groups/1179376819949373/